1h Free Analyst Time
The publisher has been monitoring the respiratory disease testing market and it is poised to grow by USD 3.52 bn during 2021-2025, progressing at a CAGR of 7.01% during the forecast period. The report on the respiratory disease testing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven rising prevalence of COPD and advancements in medical imaging testing.
The respiratory disease testing market analysis includes the type segment and geographic landscape.
The respiratory disease testing market is segmented as below:
By Type
- Imaging tests
- Mechanical tests
- In-vitro diagnostic tests
By Geographical Landscape
- North America
- Europe
- Asia
- ROW
This study identifies the initiatives by government and non-profit organizations to diagnose RSV as one of the prime reasons driving the respiratory disease testing market growth during the next few years.
The report on respiratory disease testing market covers the following areas:
- Respiratory disease testing market sizing
- Respiratory disease testing market forecast
- Respiratory disease testing market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading respiratory disease testing market vendors that include Cepheid Inc., COSMED Srl, F. Hoffmann-La Roche Ltd., Koninklijke Philips NV, NDD Medical Technologies, Nihon Kohden Corp., ResMed Inc., Seegene Inc., Smiths Group Plc, and Vyaire Medical Inc. Also, the respiratory disease testing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
Executive Summary- Market Overview
Market Landscape
- Market ecosystem
- Value chain analysis
Market Sizing
- Market definition
- Market segment analysis
- Market size 2020
- Market outlook: Forecast for 2020 - 2025
Five Forces Analysis
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
Market Segmentation by Test type
- Market segments
- Comparison by Test type
- Imaging tests - Market size and forecast 2020-2025
- Mechanical tests - Market size and forecast 2020-2025
- In-vitro diagnostic tests - Market size and forecast 2020-2025
- Market opportunity by Test type
Customer landscape
Geographic Landscape
- Geographic segmentation
- Geographic comparison
- North America - Market size and forecast 2020-2025
- Europe - Market size and forecast 2020-2025
- Asia - Market size and forecast 2020-2025
- ROW - Market size and forecast 2020-2025
- Key leading countries
- Market opportunity By Geographical Landscape
- Market drivers
- Market challenges
- Market trends
Vendor Landscape
- Overview
- Landscape disruption
Vendor Analysis
- Vendors covered
- Market positioning of vendors
- Cepheid Inc.
- COSMED Srl
- F. Hoffmann-La Roche Ltd.
- Koninklijke Philips NV
- NDD Medical Technologies
- Nihon Kohden Corp.
- ResMed Inc.
- Seegene Inc.
- Smiths Group Plc
- Vyaire Medical Inc.
Appendix
- Scope of the report
- Currency conversion rates for US$
- Research methodology
- List of abbreviations
List of Exhibits
- Key Finding 1
- Key Finding 2
- Key Finding 3
- Key Finding 5
- Key Finding 6
- Key Finding 7
- Key Finding 8
- Parent market
- Market characteristics
- Offerings of vendors included in the market definition
- Market segments
- Global - Market size and forecast 2020 - 2025 ($ million)
- Global market: Year-over-year growth 2020 - 2025 (%)
- Five forces analysis 2020 & 2025
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition - Five forces 2020
- Test type - Market share 2020-2025 (%)
- Comparison by Test type
- Imaging tests - Market size and forecast 2020-2025 ($ million)
- Imaging tests - Year-over-year growth 2020-2025 (%)
- Mechanical tests - Market size and forecast 2020-2025 ($ million)
- Mechanical tests - Year-over-year growth 2020-2025 (%)
- In-vitro diagnostic Tests - Market size and forecast 2020-2025 ($ million)
- In-vitro diagnostic Tests - Year-over-year growth 2020-2025 (%)
- Market opportunity by Test type
- Customer landscape
- Market share By Geographical Landscape 2020-2025 (%)
- Geographic comparison
- North America - Market size and forecast 2020-2025 ($ million)
- North America - Year-over-year growth 2020-2025 (%)
- Europe - Market size and forecast 2020-2025 ($ million)
- Europe - Year-over-year growth 2020-2025 (%)
- Asia - Market size and forecast 2020-2025 ($ million)
- Asia - Year-over-year growth 2020-2025 (%)
- ROW - Market size and forecast 2020-2025 ($ million)
- ROW - Year-over-year growth 2020-2025 (%)
- Key leading countries
- Market opportunity By Geographical Landscape ($ million)
- Impact of drivers and challenges
- Vendor landscape
- Landscape disruption
- Industry risks
- Vendors covered
- Market positioning of vendors
- Cepheid Inc. - Overview
- Cepheid Inc. - Product and service
- Cepheid Inc. - Key offerings
- Cepheid Inc. - Key customers
- Cepheid Inc. - Segment focus
- COSMED Srl - Overview
- COSMED Srl - Product and service
- COSMED Srl - Key offerings
- COSMED Srl - Key customers
- COSMED Srl - Segment focus
- F. Hoffmann-La Roche Ltd. - Overview
- F. Hoffmann-La Roche Ltd. - Business segments
- F. Hoffmann-La Roche Ltd. - Key offerings
- F. Hoffmann-La Roche Ltd. - Key customers
- F. Hoffmann-La Roche Ltd. - Segment focus
- Koninklijke Philips NV - Overview
- Koninklijke Philips NV - Business segments
- Koninklijke Philips NV - Key offerings
- Koninklijke Philips NV - Key customers
- Koninklijke Philips NV - Segment focus
- NDD Medical Technologies - Overview
- NDD Medical Technologies - Product and service
- NDD Medical Technologies - Key offerings
- NDD Medical Technologies - Key customers
- NDD Medical Technologies - Segment focus
- Nihon Kohden Corp. - Overview
- Nihon Kohden Corp. - Business segments
- Nihon Kohden Corp. - Key offerings
- Nihon Kohden Corp. - Key customers
- Nihon Kohden Corp. - Segment focus
- ResMed Inc. - Overview
- ResMed Inc. - Business segments
- ResMed Inc. - Key offerings
- ResMed Inc. - Key customers
- ResMed Inc. - Segment focus
- Seegene Inc. - Overview
- Seegene Inc. - Business segments
- Seegene Inc. - Key offerings
- Seegene Inc. - Key customers
- Seegene Inc. - Segment focus
- Smiths Group Plc - Overview
- Smiths Group Plc - Business segments
- Smiths Group Plc - Key offerings
- Smiths Group Plc - Key customers
- Smiths Group Plc - Segment focus
- Vyaire Medical Inc. - Overview
- Vyaire Medical Inc. - Product and service
- Vyaire Medical Inc. - Key offerings
- Vyaire Medical Inc. - Key customers
- Vyaire Medical Inc. - Segment focus
- Currency conversion rates for US$
- Research Methodology
- Validation techniques employed for market sizing
- Information sources
- List of abbreviations
Executive Summary
The publisher recognizes the following companies as the key players in the global respiratory disease testing market: Cepheid Inc., COSMED Srl, F. Hoffmann-La Roche Ltd., Koninklijke Philips NV, NDD Medical Technologies, Nihon Kohden Corp., ResMed Inc., Seegene Inc., Smiths Group Plc, and Vyaire Medical Inc.Commenting on the report, an analyst from the research team said: `The latest trend gaining momentum in the market is initiatives by government and non-profit organizations to diagnose RSV.`
According to the report, one of the major drivers for this market is the rising prevalence of COPD.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Cepheid Inc.
- COSMED Srl
- F. Hoffmann-La Roche Ltd.
- Koninklijke Philips NV
- NDD Medical Technologies
- Nihon Kohden Corp.
- ResMed Inc.
- Seegene Inc.
- Smiths Group Plc
- Vyaire Medical Inc.
